0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
ACP Journal Club |

Incretin use was not associated with increased risk for acute pancreatitis

Ann Intern Med. 2015;162(12):JC12. doi:10.7326/ACPJC-2015-162-12-012
Text Size: A A A

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment/Letter
More population based studies are required to prove that incretin based therapy is safe in regard of pancreatitis.
Posted on June 24, 2015
Gauranga Dhar
Bangladesh Institute of Family Medicine and Research
Conflict of Interest: None Declared
There are two types of incretin based anti-hyperglycemic agents; GLP-1 agonists and DPP-IV inhibitors.
In a study published in “Gastroenterology” where researchers found that exenatide (a GLP-1 agonist) users are at increased risk of pancreatitis. Researches in both human and animal models found the same result.
A recent Novo-Nordisk-sponsored trial on liraglutide, a GLP-1 agonist (phase 2 and 3; NN2211 identifiers) published in June-2015 issue of Diabetes Care found that liraglutide users are associated with increased incidences of both acute and chronic pancreatitis in comparison to glimepiride users.
Since introduction of sitagliptin in 2006 several reports of acute pancreatitis (with some cases of necrotizing pancreatitis) were submitted to the FDA.
Although cohort was large and population based, current study is confined to a specific geographical area.
More large scale multi-racial studies are required to prove the safety of incretin based therapy in regard of pancreatitis.
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)